Article Sidebar

Download
PDF

Main Article Content

Abstract

RÉSUMÉ
Objectif. Décrire les manifestations musculosquelettiques au cours du diabète type 2 en consultation de Rhumatologie au Centre Hospitalier Universitaire de Brazzaville. Patients et méthodes. Étude descriptive transversale à recueil des données prospective conduite du 1er novembre 2022 au 1er mars 2023 soit 5 mois en consultation de Rhumatologie du CHU de Brazzaville. Nous avons recherché chez les patients diabétiques type 2, adressés en consultation de rhumatologie les manifestions musculosquelettiques en rapport. Le diagnostic a été retenu sur la base des données cliniques et para cliniques (radiographie standard de face et profil et une échographie). Résultats. Nous avons inclus 116 patients dont 76 % de femmes soit un sex-ratio de 0,27. L’âge moyen des patients était de 61 ans (extrêmes de 35 à 92 ans). La durée d’évolution du diabète sucré était supérieure à 10 ans dans 42 % des cas et inférieure à 5 ans dans 35% des cas. La durée moyenne d’évolution du diabète était de 8,67 années avec des extrêmes de 0 à 36 ans. Les manifestions musculosquelettiques retrouvées étaient : la gonarthrose (49,1%), la tendinopathie de la coiffe des rotateurs (32%), le syndrome de canal carpien (29,3%), la lombarthrose (29,3%), la cervicarthrose (24,1%), le doigt à ressaut (18,1%), la tendinite de Dupuytren (14,1%), l’arthrite septique à germes banals (12,9%), la spondylodiscite infectieuse tuberculeuse (2,6%), la maladie de Forestier (2,6%), la tendinite de Dequervain (0,9% ) et la capsulite rétractile (0,9%). Conclusion. Les manifestions musculosquelettiques du diabète type 2 sont dominées par les atteintes dégénératives à savoir la gonarthrose et la tendinite de la coiffe des rotateurs. Elles méritent d’être recherchées systématiquement comme les complications micro et macroangiopathiques.
ABSTRACT
Objective. To describe the musculoskeletal manifestations of type 2 diabetes in rheumatology consultations at the Brazzaville University Teaching Hospital. Patients and methods. Cross-sectional descriptive study with prospective data collection conducted from November 1, 2022 to March 1, 2023 (5 months) in the outpatient unit of the rheumatology department of the Brazzaville University Teaching Hospital. We searched for musculoskeletal manifestations in type 2 diabetic patients referred to rheumatology consultations. The diagnosis was made on the basis of clinical and para-clinical data (standard X-ray and ultrasound scan). Results. We included 116 patients including (76% of women giving a sex ratio of 0.27. The mean age of patients was 61 years (range 35-92 years). The duration of diabetes mellitus was superior to 10 years in 42% of cases and less than 5 years in 35% of cases. The average duration of diabetes was 8.67 years, with extremes ranging from 0 to 36 years. The main musculoskeletal findings were : gonarthrosis (49.1%), rotator cuff tendinopathy (32%), carpal tunnel syndrome (29.3%), lumbar osteoarthritis (29.3%), cervicarthrosis (24.1%), jerky finger (18.1%), Dupuytren tendonitis (14,1%), common septic arthritis (12.9%), infectious tuberculous spondylodiscitis (2.6%), Forestier's disease (2.6%), Dequervain's tendonitis (0.9%) and retractile capsulitis (0.9%). Conclusion. the most common musculoskeletal manifestations of type 2 diabetes are degenerative disorders, namely gonarthrosis and rotator cuff tendonitis. They deserve to be systematically investigated, as do micro and macroangiopathic complications.

Keywords

Musculoskeletal manifestations Type2 diabetes Consultation Rheumatology Brazzaville University Hospital Manifestations musculosquelettiques Diabète type2 Consultation Rhumatologie Centre Hospitalier Universitaire de Brazzaville

Article Details

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

How to Cite
Angalla Affleck Romaric Ledier, Lamini Norbert, Andzouana Nestor, Nkouala kidédé Chabel, Akoli Ekoya, Omboumahou Bakale Francina, Salémo Anah Précieu, Ntsiba Honoré1, & Bileckot Richard. (2023). Les Manifestations Musculosquelettiques au Cours du Diabète Type 2 en Consultation de Rhumatologie au Centre Hospitalier Universitaire de Brazzaville. HEALTH SCIENCES AND DISEASE, 24(10). https://doi.org/10.5281/hsd.v24i10.4833
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. - El Hadri S, Baïzri H. Les manifestations rhumatologiques de la main et de l’épaule chez le diabétique. Rev Mar Rhum 2014; 27: 30-7.
  2. - WWW.diabetesatlas.org. IDF Diabetes Atlas2021-10TH EDITION.
  3. - Ouédraogo D D, Tiéno H, Ouédraogo L T, Sawadogo I, Nacoulma E W C, Traoré R, Drabo Y J. Manifestations rhumatologiques associées au diabète sucré chez le sujet noir africain. Médecine des maladies Métaboliques. 2009;3(5) :520-3.
  4. - Drouin P, Blicklé JF, Charbonnel B, et al. Diagnostic et classification du diabète sucré – Les nouveaux critères. Diabetes Metab.1999; 25:72-83.
  5. - Cagliero E, Apruzzese W, Gary S. Perlmutter. Musculoskeletal Disorders of the Hand and Shoulder in Patients with Diabetes Mellitus. American Journal of Médicine 2002; 112: 487–490.
  6. - Suzan M. Attar. Les manifestations rhumatologiques chez les patients diabétiques dans un centre tertiaire. Libyenne J Med. 2012; 7: 10.3402.
  7. - Ravindran Rajendran S, Bhansali A, Walia R. Prevalence and pattern of hand soft-tissue changes in type 2 diabetes mellitus. Diabetes & Metabolism.2011;37: 312–7.
  8. - Ardic F, Soyupek F, Yorgancioglu. The musculoskeletal complications seen in type II diabetics: prédominance of hand involvement. Clin Rheumatol. 2003; 22:229-233.
  9. - AFSSAPS-HAS. Recommandation Professionnelle. Traitement médicamenteux du diabète de type 2 (Actualisation). Novembre 2006. Recommandation de Bonne Pratique (Synthèse et Recommandations). Diabètes Metab 2007;33:1S1-1S105.
  10. - Penfornis A. Observance médicamenteuse dans le diabète de type 2 : influence des modalités du traitement médicamenteux et conséquence sur son efficacité. Diabetes Metab. 2003;29:S31-7.
  11. - El Fadl Y. Depistage de la néphropathie diabétique avérée dans la région Fès-boulemane (à propos de 1029 cas). Thèse n° 072/2010 Faculté de Médecine et de Pharmacie Fès
  12. - El Youssfi S. Néphropathie diabétique lors de la première Consultation en néphrologie (à propos de 104 cas). Thèse n° 029/2011 Faculté de Médecine et de Pharmacie Fès.
  13. - Van Sloten TT, Savelberg HH, Duimel-Peeters IG et al. Peripheral neuropathy, decreased muscle strength and obesity are strongly associated with walking in persons with type 2 diabetes without manifest mobility limitations. Diabetes res clin pract. 2011; 91:32–9.
  14. - Berenbaum F. Diabetes-induced Osteoarthritis: From a New Paradigm to a New Phenotype. Postgrad Med J. 2012;88 (1038):240-2.
  15. - Esposito K, Nappo F, Marfella R, ET AL. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation.2002; 106:2067–72.
  16. - Igarashi M, Wakasaki H, Takahara N et al. Glucose or diabetes activates p38 mitogen-activated protein kinase via different pathways. J clin invest 1999;103:185–95.
  17. - Stannus O, Jones G, Cicuttini F, ET AL. Circulating levels of IL-6 and TNF-a are associated with knee radiographic osteoarthritis and knee cartilage loss in older adults. Osteoarthr Cartil. 2010; 18:1441–7.
  18. - Thomas SJ, McDougall C, Brown ID et al. Prevalence of symptoms and signs of shoulder problems in people with diabetes mellitus. J Shoulder Elbow Surg 2007; 16:748-51.
  19. - Laslett LL, Burnet SP, Jones JA, et al. Musculoskeletal morbidity: the growing burden of shoulder pain and disability and poor quality of life in diabetic outpatients. Clin Exp Rheumatol. 2007;25:422-9.
  20. - Eti E, Daboiko JC, Ouali B, et al. Complications ostéoarticulaires du diabète sucré en milieu hospitalier ivoirien (à propos de 188 diabétiques). Afr Biomed 2001;6:37-43.
  21. - Bergaoui N, Jribi C, Achour A, et al. Les manifestations rhumatologiques au cours du diabète sucré. Vues à travers une étude prospective de 280 diabétiques et 100 témoins. Sem Hop Paris.1991; 67:1056-61.
  22. - Arkkila PE, Kantola IM, Viikari JS, Rönnemaa T. Shoulder capsulitis in type I and II diabetic patients: association with diabetic complications and related diseases. Ann Rheum Dis 996; 55:907-14.
  23. - Pal B, Anderson J, Dick WC, Griffiths ID. Limitation of joint mobility and shoulder capsulitis in insulin and non-insulin-dependent diabetes mellitus. British Journal of Rheumatology 1986; 25: 147–151.
  24. - Bridgman JF. Periarthritis of the shoulder and diabetes mellitus. Ann Rheum Dis
  25. ; 31: 69-71.
  26. - Balci N, Balci MK, Tüzüner S. Shoulder adhesive capsulitis and shoulder range of motion in type II diabetes mellitus: association with diabetic complications. J Diabetes Complications. 1999;13:135-40
  27. - Moren-Hybbinette I, Moritz U, Schersten B. The clinical picture of the painful diabetic shoulder. Natural history, social consequences and analysis of concomitanthand syndrome. Acta Med Scand 1987;221: 73-82.
  28. - Perkins BA, Olaleye D, Bril V. Carpal tunnel syndrome in patients with diabetic polyneuropathy. Diabetes Care 2002;25:565-9.
  29. - Kayali H, Kahraman S, Sirin S, et al. Bilateral carpal tunnel syndrome with type 1 diabetes mellitus in childhood. Pediatr Neurosurg. 2003;38:262-4.
  30. - Gamstedt A, Holm-Glad J, Ohlson CG, Sundstra`m M. Hand abnormalities are strongly associated with the duration of diabetes mellitus. J Intern Med 1993;234:189.
  31. - Gulliford MC, Latinovic R, Charlton J, Hughes RA. Increased incidence of carpal tunnel syndrome up to 10 years before diagnosis of diabetes. Diabetes Care 2006;29:1929.
  32. - Chammas M, Bousquet P, Renard E, et al. Dupuytren’s disease, carpal tunnel syndrome, trigger finger, and diabetes mellitus. J Hand Surg Am. 1995;20: 109-14.
  33. - Serban AL, Udrea GF. Rheumatic manifestations in diabetic patients. J Med Life 2012;5:2527.
  34. - Blyth MJ, Ross DJ. Diabetes and trigger finger. J Hand Surg Br 1996;21:244-5.
  35. - Yosipovitch G, Yosipovitch Z, Karp M, Mukamel M. Trigger finger in young patients with insulin dependent diabetes. J Rheumatol 1990;17: 951-2.
  36. - Nimigan AS, Ross DC, Gan BS. Steroid injections in the management of trigger fingers. Am J Phys Med Rehabil 2006;85:36-43.
  37. - Gavet F, Tournadre A, Soubrier M, Ristori JM, Dubost JJ. Septic arthritis in patients aged 80 and older: a comparison with younger adult. J Am Geriatr Soc 2005;53:1210–3.
  38. - Al-Nammari SS, Lucas JD, Lam KS. Hematogenous methicillinresistant Staphylococcus aureus spondylodiscites. Spine 2007; 32: 2480-6.
  39. - Weston VC, Jones AC, Bradbury N, Fawthrop F, Doherty M. Clinical features and outcome of septic arthritis in a single UK Health District 1982-1991. Ann Rheum Dis.1999;58:214-9.
  40. - Kaandorp CJ, Van Schaardenburg D, Krijnen P, Habbema JD, Van de Laar MA. Risk factors for septic arthritis in patients with joint disease. Arthritis Rheum.1995;38:1819-25.
  41. - Kiss C, Szilagyi M, PaskyA, Poor G. Risk factors for diffuse idiopathic skeletal hyperostosis: a case-control study. Rheumatol 2002;41:27-30.
  42. - Joel D Taurog, Peter E Lipsky. Ankylosing Spondylitis, reactive arthritis, and undifferentiated spondyloarthropathy. In: Anthony S. Fauci et al (eds): Harrison’s principles of internal medicine, 14th Edn, The McGraw-Hill Companies.1998;2:1904-6.
  43. - Boachie-Adjei O, Bullough PG. Incidence of ankylosing hyperostosis of the spine (Forestier’s disease) at autopsy. Spine 1987;12: 739e43.
  44. - Anneloes Westervel D, Henriette M.E, Cumhur oner F. The Prevalence of Diffuse Idiopathic Skeletal Hyperostosis in an Outpatient Population in the Netherlands. The Journal of Rheumatology. 2008 vol. 35 no. 8 1635-1638.
  45. - Weinfeld RM, Olson PN, Maki DD, Griffiths HJ. The prevalence of diffuse idiopathic skeletal hyperostosis (DISH) in two large American Midwest metropolitan hospital populations. Skeletal Radiol. 1997;26: 222e5.
  46. - Ashish.J, Mathew, Jayakumar. Rheumatic musculoskeletal manifestations in type 2 diabetes mellitus patients in south India. International Journal of Rheumatic Diseaes 2011 ; 14 :55-60.
  47. - Fautrel B. Complications musculosquelettiques du diabete.Rev Rhum Monograph 2011;78(4):239-45.
  48. - Burke FD, Proud G, Lawson IJ, et al. An assessment of the effects of exposure to vibration, smoking, alcohol and diabetes on the prevalence of Dupuytren’s disease in 97,537 miners. J Hand Surg Eur Vol 2007;32:400–6.
  49. - Lawson.P and all. The relationship of hand abnormalities to diabetes and diabetic retinopathy. Diaetes Care. 1983 ; 6 :140-146.
  50. - JenningsAM, Milner PC,Ward JD. Hand abnormalities are associated with the complications of diabetes in type II diabetes. DiabetMed1989; 6:43-7.
  51. - Kishcner. CW. Microvascular changes in Dupuytren´s contracture. J Hand Surg 1984 ; 9A :58-62.

Most read articles by the same author(s)

Similar Articles

You may also start an advanced similarity search for this article.